Company / Operating Cash Flow
Coherus Oncology, Inc. Operating Cash Flow History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$28.4M
FY2019
5-year range
-$200.3M / $28.4M
FY2015-FY2019
Trend
+117.8%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$200M to $28M over the past 2 years.
Based on SEC 10-K filings.
$28M in FY2019.
Improved from -$200M to $28M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating cash flow increased 117.8% year-over-year.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $28.4M | +117.8% |
| FY2018 | -$159.3M | +20.5% |
| FY2017 | -$200.3M | -737.1% |
| FY2016 | -$23.9M | -255.1% |
| FY2015 | $15.4M | +184.5% |
| FY2014 | -$18.3M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026